In a historic move, the U.S. Drug Enforcement Agency announced in late April 2024 that it plans to ease federal restrictions on cannabis, signaling an acknowledgment of its promising medicinal value. Also growing popular in the alternative medicine space is psilocybin, the active component in magic mushrooms. Kevin Boehnke, assistant professor of anesthesiology and an expert in alternative pain management options, breaks down how these developments may affect how people use cannabis and psilocybin as potential tools for pain management.